High-Volume Oral Dose & Injectable Manufacturing - PiSA USA

PiSA’s Oncological and Immunosuppressant Manufacturing facility can currently produce 10 million doses of injectables and 500 million doses of oral solids annually. PiSA’s Immunosuppressant facility has the capacity to produce 200 million capsules, tablets, and vials.